Olimab 60 mg/ml PFS Injection is used for the treatment of osteoporosis (a condition where bone density reduces and bones becomes weak and fragile) in men and postmenopausal women who are at high risk for fractures and have failed to respond to other medication treatments for osteoporosis. It is also used for the treatment of bone loss in men with prostate cancer and women with breast cancer receiving therapy with medications that cause bone loss. This medicine also reduces the risk of fractures in patients with bone cancer and multiple myeloma (a type of blood cancer).